The difficult-to-treat, therapy-resistant cough: Why are current cough treatments not working and what can we do?

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 5, 2013, Pages 528-531

  McGarvey, Lorcan ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cough; Idiopathic; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; CISAPRIDE; CORTICOSTEROID; GABAPENTIN; MACROLIDE; MORPHINE; OPIATE; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ARTICLE; CHRONIC COUGH; COUGHING; DRUG EFFICACY; DRUG TREATMENT FAILURE; HUMAN; LOW DRUG DOSE; MEDICATION COMPLIANCE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT DURATION; TREATMENT RESPONSE;

COUGH; IDIOPATHIC; TREATMENT;

ANALGESICS, OPIOID; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIDEPRESSIVE AGENTS; ANTITUSSIVE AGENTS; CHRONIC DISEASE; COUGH; DRUG RESISTANCE; GUIDELINE ADHERENCE; HUMANS; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SPEECH THERAPY;

EID: 84882583568     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2013.05.001     Document Type: Article

References (47)

1. Fendrick A.M., Monto A.S., Nightengale B., Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the united states. Arch Intern Med 2003, 163(4):487-494.
2. Schappert S.M., Rechtsteiner E.A. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 2011 Apr, 13(169):1-38.
3. McGarvey L., Heaney L.G., MacMahon J. Aretrospective survey of diagnosis and management of patients presenting with chronic cough to a general chest clinic. Int J Clin Pract 1998 Apr-May, 52(3):158-161.
4. Morice A.H., Fontana G.A., Sovijarvi A.R., Pistolesi M., Chung K.F., Widdicombe J., et al. The diagnosis and management of chronic cough. Eur Respir J 2004 Sep, 24(3):481-492.
5. Morice A.H., McGarvey L., Pavord I. Recommendations for the management of cough in adults. Thorax 2006 Sep, 61(Suppl. 1):i1-24. British Thoracic Society Cough Guideline Group.
6. Shields M.D., Bush A., Everard M.L., McKenzie S., Primhak R. BTS guidelines: recommendations for the assessment and management of cough in children. Thorax 2008, 63(Suppl. 3):iii1-iii15. British Thoracic Society Cough Guideline Group.
7. Irwin R.S., Corrao W.M., Pratter M.R. Chronic persistent cough in the adult: the spectrum and frequency of cases and successful outcome of specific therapy. Am Rev Respir Dis 1981, 123:414-417.
8. McGarvey L.P., Heaney L.G., Lawson J.T., Johnston B.T., Scally C.M., Ennis M., et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax 1998, 53(9):738-743.
9. Pratter M.R. Unexplained (idiopathic) cough: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(1 Suppl.):220S-221S.
10. McGarvey L.P. Idiopathic chronic cough: a real disease or a failure of diagnosis?. Cough 2005, 1:9.
11. Reich J.M. Chronic idiopathic cough: self-sustaining?. Chest 2007, 131(2):636. author reply 637.
12. Sundar K.M., Daly S.E., Pearce M.J., Alward W.T. Chronic cough and obstructive sleep apnea in a community-based pulmonary practice. Cough 2010 Apr 15, 6(1):2.
13. Birring S.S., Passant C., Patel R.B., Prudon B., Murty G.E., Pavord I.D. Chronic tonsillar enlargement and cough: preliminary evidence of a novel and treatable cause of chronic cough. Eur Respir J 2004, 23(2):199-201.
14. Ogawa H., Fujimura M., Takeuchi Y., Makimura K. Efficacy of itraconazole in the treatment of patients with chronic cough whose sputa yield basidiomycetous fungi-fungus-associated chronic cough (FACC). JAsthma 2009 May, 46(4):407-412.
15. Wood J., Butler C.C., Hood K., Kelly M.J., Verheij T., Little P., et al. Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines. Eur Respir J 2011 Jul, 38(1):112-118.
16. Lin L., Poh K.L., Lim T.K. Empirical treatment of chronic cough - a cost-effectiveness analysis. Proc AMIA Symp 2001, 383-387.
17. Field S.K., Conley D.P., Thawer A.M., Leigh R., Cowie R.L. Effect of the management of chronic cough patients by pulmonologists and certified respiratory educators on quality of life: a randomized trial. Chest 2009, 136(4):1021-1028.
18. Chang A.B., Robertson C.F., Paul van Asperen P., Glasgow N.J., Masters I.B., Teoh L., et al. Acough algorithm for chronic cough in children: a multicenter, randomized controlled study. Pediatrics 2013, 131(5):e1576-e1583.
19. Heaney L.G., Horne R. Non-adherence in difficult asthma: time to take it seriously. Thorax 2012, 67(3):268-270.
20. Jentzsch N.S., Camargos P., Sarinho E.S., Bousquet J. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med 2012 Mar, 106(3):338-343.
21. Chheda N.N., Postma G.N. Patient compliance with proton pump inhibitor therapy in an otolaryngology practice. Ann Otol Rhinol Laryngol 2008 Sep, 117(9):670-672.
22. Gamble J., Stevenson M., Heaney L.G. Astudy of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir Med 2011, 105(9):1308-1315.
23. Patterson R.N., Johnston B.T., MacMahon J., Heaney L.G., McGarvey L.P. Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough". Eur Respir J 2004, 24(5):724-727.
24. Prieto L., Ferrer A., Ponce S., Palop J., Marin J. Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough. Chest 2009, 136(30):816-822.
25. Sato S., Saito J., Sato Y., Ishii T., Xintao W., Tanimo Y., et al. Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. Respir Med 2008, 102:1452-1459.
26. Williamson I.J., Matusiewicz S.P., Brown P.H., Greening A.P., Crompton G.K. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995 Apr, 8(4):590-592.
27. Richter J.E. Cisapride: limited access and alternatives. Cleve Clin J Med 2000 Jul, 67(7):471-472.
28. Schaefer M.K., Shehab N., Cohen A.L., Budnitz D.S. Adverse events from cough and cold medications in children. Pediatrics 2008, 121:783-787.
29. Centers for Disease Control and Prevention (CDC) Revised product labels for pediatric over-the-counter cough and cold medicines. MMWR Morb Mortal Wkly Rep 2008, 57:1180.
30. Hermos J.A., Young M.M., Fonda J.R., Gagnon D.R., Fiore L.D., Lawler E.V. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed. Clin Infect Dis 2012, 54(1):33-42.
31. Khalili H., Huang E.S., Jacobson B.C., Camargo C.A., Feskanich D., Chan A.T. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. Br Med J 2012 Jan 30, 344:e372.
32. Preti D., Szallasi A., Patacchini R. TRP channels as therapeutic targets in airway disorders: a patent review. Expert Opin Ther Pat 2012, 22(6):663-695.
33. Davenport P.W., Vovk A., Duke R.K., Bolser D.C., Robertson E. The urge-to-cough and cough motor response modulation by the central effects of nicotine. Pulm Pharmacol Ther 2009, 22:82-89.
34. Van den Bergh O., Van der Stappen E., Silva M., Van Diest I., Davenport P., Dupont L. Associative learning of coughing and the urge-to-cough: an explorative study. Biol Psychol 2010, 85:518.
35. Van den Bergh O., Van Diest I., Dupont L., Davenport P.W. On the psychology of cough. Lung 2012 Feb, 190(1):55-61.
36. Yousaf N., Monteiro W., Parker D., Matos S., Birring S., Pavord I.D. Long-term low-dose erythromycin in patients with unexplained chronic cough: a double-blind placebo controlled trial. Thorax 2010 Dec, 65(12):1107-1110.
37. Jeyakumar A., Brickman T.M., Haben M. Effectiveness of amitriptyline versus cough suppressants in the treatment of chronic cough resulting from postviral vagal neuropathy. Laryngoscope 2006 Dec, 116(12):2108-2112.
38. Morice A.H., Menon M.S., Mulrennan S.A., Everett C.F., Wright C., Jackson J., et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med 2007 Feb 15, 175(4):312-315.
39. Vertigan A.E., Theodoros D.G., Gibson P.G., Winkworth A.L. Efficacy of speech pathology management for chronic cough: a randomised placebo controlled trial of treatment efficacy. Thorax 2006 Dec, 61(12):1065-1069.
40. Ryan N.M., Birring S.S., Gibson P.G. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012 Nov 3, 380(9853):1583-1589.
41. Morjaria J.B., Dickinson R.S., Morice A.H. Novel antitussive strategies. Drug Discov Today 2013, 18(7-8):380-388.
42. Undem B.J., Carr M.J. Targeting primary afferent nerves for novel antitussive therapy. Chest 2010 Jan, 137(1):177-184.
43. Birring S.S. Developing antitussives: the ideal clinical trial. Pulm Pharmacol Ther 2009 Apr, 22(2):155-158.
44. Gibeon D., Batuwita R., Osmond M., Heaney L.G., Brightling C.E., Niven R.M., et al. Obesity associated severe asthma represents a distinct clinical phenotype - analysis of the British Thoracic Society difficult asthma registry patient cohort according to body mass index. Chest 2013, 143(2):406-414.
45. Barton A., Gaydecki P., Holt K., Smith J.A. Data reduction for cough studies using distribution of audio frequency content. Cough 2012 Dec 12, 8(1):12.
46. Lee K.K., Savani A., Matos S., Evans D.H., Pavord I.D., Birring S.S. 4-hour cough frequency monitoring in chronic cough. Chest 2012, 142(5):1237-1243.
47. Eccles R. Importance of placebo effect in cough clinical trials. Lung 2010, 188(Suppl. 1):S53-61.